BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang S, Long S, Deng Z, Wu W. Positive Role of Chinese Herbal Medicine in Cancer Immune Regulation. Am J Chin Med 2020;48:1577-92. [DOI: 10.1142/s0192415x20500780] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Li X, Ning M, Han L, Junfeng Y, Qinghua P. Analysis of the hotspots and trends in traditional Chinese medicine immunomodulation research based on bibliometrics. Digital Chinese Medicine 2021;4:81-91. [DOI: 10.1016/j.dcmed.2021.06.002] [Reference Citation Analysis]
2 El-Gogary RI, Nasr M, Rahsed LA, Hamzawy MA. Ferulic acid nanocapsules as a promising treatment modality for colorectal cancer: Preparation and in vitro/in vivo appraisal. Life Sci 2022;298:120500. [PMID: 35341825 DOI: 10.1016/j.lfs.2022.120500] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Lu C, Ke L, Li J, Wu S, Feng L, Wang Y, Mentis AFA, Xu P, Zhao X, Yang K. Chinese Medicine as an Adjunctive Treatment for Gastric Cancer: Methodological Investigation of meta-Analyses and Evidence Map. Front Pharmacol 2021;12:797753. [PMID: 35082677 DOI: 10.3389/fphar.2021.797753] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Ding R, Jiao L, Sang S, Yin Y, Wang Y, Gong Y, Xu L, Bi L. Anticancer Action of Xiaoxianxiong Tang in Non-Small Cell Lung Cancer by Pharmacological Analysis and Experimental Validation. Evid Based Complement Alternat Med 2021;2021:9930082. [PMID: 34938346 DOI: 10.1155/2021/9930082] [Reference Citation Analysis]
5 Zhang S, Chen W, Wang Y, Wu J, Xu L, Yu Y, Tian J, Xu R, Fang Z, Jiang L, Luo Y, Li Y. Chinese Herbal Prescription Fu-Zheng-Qu-Xie Prevents Recurrence and Metastasis of Postoperative Early-Stage Lung Adenocarcinoma: A Prospective Cohort Study Followed with Potential Mechanism Exploration. Oxid Med Cell Longev 2021;2021:6673828. [PMID: 34055197 DOI: 10.1155/2021/6673828] [Reference Citation Analysis]
6 Zhou M, Li J, Luo D, Zhang H, Yu Z, Chen Y, Li Q, Liang F, Chen R. Network Pharmacology and Molecular Docking-Based Investigation: Prunus mume Against Colorectal Cancer via Silencing RelA Expression. Front Pharmacol 2021;12:761980. [PMID: 34867383 DOI: 10.3389/fphar.2021.761980] [Reference Citation Analysis]
7 Xu L, Yang H, Hu R, Liang Y, Li Y, Xu W, Fan X, Liu Y. Comparing the interaction of four structurally similar coumarins from Fraxinus Chinensis Roxb. with HSA through multi-spectroscopic and docking studies. Journal of Molecular Liquids 2021;340:117234. [DOI: 10.1016/j.molliq.2021.117234] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Yan J, Yan Y, Young A, Yan Z, Yan Z. Effectiveness and Safety of Chinese Medicine Decoctions for Behcet's Disease: A Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med 2021;2021:8202512. [PMID: 34335839 DOI: 10.1155/2021/8202512] [Reference Citation Analysis]
9 Wang CZ, Wan C, Luo Y, Zhang CF, Zhang QH, Chen L, Liu Z, Wang DH, Lager M, Li CH, Jiang TL, Hou L, Yuan CS. Effects of dihydroartemisinin, a metabolite of artemisinin, on colon cancer chemoprevention and adaptive immune regulation. Mol Biol Rep 2022. [PMID: 35040004 DOI: 10.1007/s11033-021-07079-1] [Reference Citation Analysis]
10 Chen F, Li J, Wang H, Ba Q. Anti-Tumor Effects of Chinese Medicine Compounds by Regulating Immune Cells in Microenvironment. Front Oncol 2021;11:746917. [PMID: 34722304 DOI: 10.3389/fonc.2021.746917] [Reference Citation Analysis]
11 Cui HR, Zhang JY, Cheng XH, Zheng JX, Zhang Q, Zheng R, You LZ, Han DR, Shang HC. Immunometabolism at the service of traditional Chinese medicine. Pharmacol Res 2022;:106081. [PMID: 35033650 DOI: 10.1016/j.phrs.2022.106081] [Reference Citation Analysis]
12 Jiang H, Mao T, Liu Y, Tan X, Sun Z, Cheng Y, Han X, Zhang Y, Wang J, Shi L, Guo Y, Li J, Han H. Protective Effects and Mechanisms of Yinchen Linggui Zhugan Decoction in HFD-Induced Nonalcoholic Fatty Liver Disease Rats Based on Network Pharmacology and Experimental Verification. Front Pharmacol 2022;13:908128. [PMID: 35721171 DOI: 10.3389/fphar.2022.908128] [Reference Citation Analysis]
13 Guerra-Martín MD, Tejedor-Bueno MS, Correa-Casado M. Effectiveness of Complementary Therapies in Cancer Patients: A Systematic Review. Int J Environ Res Public Health 2021;18:1017. [PMID: 33498883 DOI: 10.3390/ijerph18031017] [Reference Citation Analysis]
14 Liu C, Yu H, Li X, Gong Y, Wu P, Feng QS. Anti-hepatocellular carcinoma efficacy of Fuzheng Xiaozheng prescription and its interventional mechanism studies. J Ethnopharmacol 2022;285:114913. [PMID: 34910953 DOI: 10.1016/j.jep.2021.114913] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Lee K, Youn BY, Choi YJ, Moon S, Im J, Cho K, Ko SG, Cheon C. State of the Art and Future Implications of SH003: Acting as a Therapeutic Anticancer Agent. Cancers (Basel) 2022;14:1089. [PMID: 35205836 DOI: 10.3390/cancers14041089] [Reference Citation Analysis]
16 Huang Q, Lin J, Huang S, Shen J. Impact of Qi-Invigorating Traditional Chinese Medicines on Diffuse Large B Cell Lymphoma Based on Network Pharmacology and Experimental Validation. Front Pharmacol 2021;12:787816. [PMID: 34955857 DOI: 10.3389/fphar.2021.787816] [Reference Citation Analysis]
17 Yu B, Lv G, Sohail M, Li Z, Li Y, Yu M, Sun F, Xu H, Lau ATY. Utilizing Bioinformatics Technology to Explore the Potential Mechanism of Danggui Buxue Decoction against NSCLC. Disease Markers 2022;2022:1-20. [DOI: 10.1155/2022/5296830] [Reference Citation Analysis]
18 Song H, Wei C, Yang W, Niu Z, Gong M, Hu H, Wang H. Alpinetin suppresses CYP3A4, 2C9, and 2E1 activity in vitro. Pharmaceutical Biology 2022;60:1032-7. [DOI: 10.1080/13880209.2022.2071450] [Reference Citation Analysis]